1,720,986 research outputs found
Un distillato Bohémienne tuttora famoso: l’assenzio
No full textL'assenzio è un distillato ad alta gradazione alcolica 60-70° all'aroma di anice, generalmente dalla colorazione verde smeraldo o verde chiaro, derivato da erbe quali i fiori e le foglie dell’Artemisia absinthium L. dal quale prende il nome. Le proprietà officinali della pianta sono conosciute ed utilizzate fin dall’antichità dal momento che la pianta e le sue applicazioni terapeutiche sono addirittura citate in un papiro egiziano del 1500 a.C. Tale distillato conobbe una diffusione eccezionale nell’800, e divenne particolarmente noto alla fine del secolo, grazie alla fama che ebbe tra gli artisti e gli scrittori di Parigi. Il successo dell’assenzio in Europa fu clamoroso, ma altrettanto rapido fu poi il suo declino. Infatti, scomparve da tutti i mercati d’Europa e d’oltre oceano in poco più di un decennio. Attualmente l’assenzio, ritornato in voga, trova applicazione durante la celebrazione di numerose ritualità magico-esoteriche dove lo si celebra come capace di ridurre la carica aggressiva, sviluppare la calma e fortificare corpo e mente. Siti internet di matrice magico-occultista riportano il suo consumo durante lo svolgimento di vari rituali. Questo utilizzo “nascosto” ma diffuso ha posto le basi per indagarne il suo reale consumo voluttuario tra i giovani, in considerazione della sua facile reperibilità e dei suoi effetti farmaco-tossicologici
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa
Full text linkIl numero di nuove sostanze psicoattive (NSP) acquistabile in internet e le informazioni relative alla loro modalità di assunzione a scopi curativi, ricreazionali e spirituali, stanno aumentando costantemente. Nomi come “legal highs”, “herbal highs” e “etno-drugs”, inducono i consumatori a credere che questi prodotti siano sicuri e naturali, sottostimandone o volutamente trascurandone le loro potenzialità farmaco-tossicologiche. Oltre a questo, l’impiego di sostanze naturali tradizionalmente impiegate all’interno di un rituale ben definito in etnie specifiche, in nuovi contesti ricreativi, porta spesso all’abuso delle stesse sostanze (Marti, 2013; 2015). Infatti, mentre l’uso tradizionale/etnico di queste sostanze naturali, non sembra essere associato a dipendenza, intossicazioni o problemi legati alla salute, una volta raggiunto il mercato mondiale, si assiste invece ad una escalation di problematiche ed intossicazioni. Queste derivano soprattutto dal fatto che uscendo da un contesto tradizionale per accedere in uno prettamente ricreazionale, cambiano numerosi fattori fondamentali tra cui: la via di somministrazione, la quantità assunta, l’assunzione di sostanze pure e la co-somministrazione con altre sostanze psicoattive
Ayahuasca: il vino dell'anima
No full textAyahuasca in lingua Quechua viene tradotto come Aya, anima, spirito, antenato o persona defunta; huasca liana, corda; significa perciò “liana dei morti”. Anche nota come yagé, caapi, natem, è il più importante allucinogeno della foresta amazzonica che viene consumato tradizionalmente dagli sciamani di numerose comunità indigene brasiliane nel corso di sessioni terapeutico/spirituali. Tuttavia il suo utilizzo con il passare dei secoli, la colonizzazione e la globalizzazione si è progressivamente modificato, generando nuove modalità di consumo all’interno di vari contesti ritualistici che vanno da quello turistico, a quello psichedelico puro, fino anche a quello magico/esoterico con ricadute criminogen
Trichocereuspachanoi: quando la globalizzazione minaccia la tradizione
Full text linkNegli ultimi anni, nello specifico dal 2010 al 2015, sono state intercettate dall’Early Warning System più di 560 nuove sostanze psicoattive tra cui anche piante ed estratti vegetali. All’interno di questo panorama, si inserisce il sanpedro, un cactus mescalinico appartenente al genere Echinopsis o Trichocereus usato dalle popolazioni andine dell’Equador, Bolivia e in modo particolare del Perù, per scopi mistico e medico-curativi. La bevanda a base di mescalina, da qualche decennio ha varcato i confini storico-culturali nella quale era inserita, approdando anche nei mercati europei e in quello nazionale. Oggigiorno infatti, il sanpedro, eradicato dal proprio contesto mistico-religioso, grazie al suo contenuto mescalinico e alla facile reperibilità via internet, trova ampio spazio come sostanza d`abuso a scopi puramente ricreativi. In Italia, sebbene la mescalina sia inserita tra le sostanze stupefacenti e psicotrope e dunque considerata una sostanza illegale, la coltivazione e il consumo del cactus è ad oggi consentita. La legittimità di coltivare e consumare piante i cui principi attivi dimostrano avere effetti psicoattivi, ha favorito la diffusione su larga scala, di una nuova frontiera del mercato delle sostanze d`abuso
Case Report: Nephrocalcinosis in an infant due to vitamin-D food supplement overdose
Full text linkBackground Vitamin D is a vital lipophilic vitamin that plays a pivotal role in calcium regulation, bone metabolism, and overall health. It is of the utmost importance to maintain appropriate serum levels of vitamin D from the moment of birth. The recommended daily intake for infants under the age of 12 months is 400 IU. In Europe, vitamin D is available in two forms: as a medicinal product and as a food supplement. The food supplement market is experiencing rapid growth, yet it is characterised by a lack of harmonised regulations, which may give rise to potential risks associated with their widespread use. While food supplements are typically regarded as safe, there is a potential for adverse effects, particularly when dosages are not properly managed.Case report and management This report presents the case of a 22-month-old girl who developed nephrocalcinosis as a result of an overdose of vitamin D from a dietary supplement purchased online. The initial presentation was characterised by symptoms such as polydipsia, polyuria and decreased growth. It was subsequently revealed that the child had been receiving an excessively high dose of vitamin D, amounting to 25 times the recommended amount, over a period of seven months. Despite normal calcium levels and renal function at the time of presentation, ultrasound imaging revealed the presence of early-stage nephrocalcinosis. The treatment plan involved hospital admission, intravenous hydration, a thiazide diuretic, potassium citrate, and a low-calcium diet. The vitamin D supplement was ceased. Over the course of a year, the patient demonstrated recovery in growth and normalization of vitamin D levels, although nephrocalcinosis remained stable.Conclusion This case study highlights the potential dangers of unsupervised vitamin D supplementation, emphasising the importance of healthcare professionals exercising vigilance in prescribing and advising on vitamin D use, particularly in children. Furthermore, it underscores the necessity of establishing a database to track long-term outcomes in paediatric vitamin D intoxication cases, given the rarity of such incidents. This would facilitate the development of appropriate treatment protocols and provide valuable information to parents
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity
Full text linkPurpose: MDMA is a psychoactive drug that has been increasingly abused worldwide, due to its entactogenic properties. However, concerns on its safety exist, particularly regarding its effects on attentional skills and performance. Evidence from the literature shows contrasting effects of MDMA. It generally acts as a pshychomotor stimulant, thus improving arousal and psychomotor function. However, MDMA has been demonstrated to negatively influence other skills. Consequently, human activities that require alertness, and accurate and quick reflexes (i.e. driving, operations at the workplace, etc.) could be negatively affected. In the present study, the effect of MDMA (0.1–20 mg/kg, intraperitoneally) on sensorimotor and startle/prepulse inhibition responses was evaluated in a controlled rodent experimental setting. Methods: Sensorimotor studies, evaluation of visual, acoustic, and tactile responses, evaluation of spontaneous locomotion, startle and repulse inhibition analyses were performed in an experimental controlled rodent model (rats and mice), following the administration of MDMA (0.1–20 mg/kg) intraperitoneally. Results: Our findings show that all the MDMA-treated animals had impaired sensorimotor and prepulse inhibition responses compared to the control subjects at the early (5, 30 and 60 min) testing time points while all the effects disappeared, respectively, 6, 16 and 24 h post-MDMA treatment. Conclusions: Within the ongoing debate on the safety of recreational abuse of MDMA, our results reveal acute prominent changes in sensorimotor and attentional performance, sensor response to external stimuli, and locomotor activity due to a single administration of a dose of MDMA (corresponding to a dose producing in humans both ‘desirable’ entactogenic effects and physiological adverse effects)
JWH-018 impairs sensorimotor functions in mice
No full textNaphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) is a synthetic cannabinoid agonist illegally marketed in "Spice" and "herbal blend" for its psychoactive effect greater than those produced by cannabis. In rodents JWH-018 reproduces typical effects of (-)-Δ(9)-THC or Dronabinol® (Δ(9)-THC) such as hypothermia, analgesia, hypolocomotion and akinesia, while its effects on sensorimotor functions are still unknown. Therefore, the aim of the present study is to investigate the effect of acute administration of JWH-018 (0.01-6mg/kg i.p.) on sensorimotor functions in male CD-1 mice and to compare its effects with those caused by the administration of Δ(9)-THC (0.01-6mg/kg i.p.). A specific battery of behavioral tests were adopted to investigate effects of cannabinoid agonists on sensorimotor functions (visual, auditory, tactile) and neurological changes (convulsion, myoclonia, hyperreflexia) while video-tracking analysis was used to study spontaneous locomotion. JWH-018 administration inhibited sensorimotor responses at lower doses (0.01-0.1mg/kg), reduced spontaneous locomotion at intermediate/high doses (1-6mg/kg) and induced convulsions, myoclonia and hyperreflexia at high doses (6mg/kg). Similarly, administration of Δ(9)-THC reduced sensorimotor responses in mice but it did not inhibit spontaneous locomotion and it did not induce neurological alterations. All behavioral effects and neurological alterations were prevented by the administration of the selective CB1 receptor antagonist/inverse agonist 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (AM 251). For the first time these data demonstrate that JWH-018 impairs sensorimotor responses in mice. This aspect should be carefully evaluated to better understand the potential danger that JWH-018 may pose to public health, with particular reference to decreased performance in driving and hazardous works
Dabigatran-Induced Nephropathy and Gastrointestinal Bleeding and Its Successful Treatment with Idarucizumab: A Case Report
Full text linkRecently, the atrial fibrillation treatment guidelines have been updated to now recommend Non-vitamin K antagonist oral anticoagulants (NOACs) as the preferred alternative to warfarin for systemic embolism and stroke prevention in patients with non-valvular atrial fibrillation. NOACs have major pharmacologic advantages over warfarin, although the most common complications are gastrointestinal bleeding and NOAC-induced nephropathy within 6 weeks after starting therapy, as several recent case-reports stated. We are reporting for the first time a chronic delayed adverse reaction (regularly reported to Authorities) observed in an 82-year-old woman 27 months after starting dabigatran (110 mg twice a day), characterized by concomitant gastrointestinal bleeding and nephropathy. Idarucizumab administration immediately improved both bleeding and renal parameters. Moreover, we are going to highlight the importance of the compliance, the adherence to the therapeutic plan and the supervision of the Hospital Pharmacy on drug prescriptions. In fact in our case, dabigatran was firstly prescribed by the neurologist and delivered by the hospital pharmacy, but the patient continued the treatment for 27 months, prescribed by general practitioner without any laboratory control. This lack of supervision certainly contributed to the onset of the adverse reaction reported
- …
